News & Media

Press Releases

Amolyt Pharma Announces Two Presentations, Including Phase 2a Data for AZP-3601 in Patients with Hypoparathyroidism, at the American Society for Bone and Mineral Research 2022 Annual Meeting

September 1, 2022

Download a PDF: EN or FR

Amolyt Pharma Strengthens Leadership Team with Appointment of Mark Sumeray, M.D., as Chief Medical Officer

June 29, 2022

Download a PDF: EN or FR

Amolyt Pharma Announces Positive Results from First Patient Cohort of Phase 2a Trial of AZP-3601 for the Treatment of Hypoparathyroidism

June 1, 2022

Download a PDF: EN or FR

Presentations

Eneboparatide (AZP-3601)

KOL Webinar on AZP-3601 Featuring John P. Bilezikian, M.D., Ph.D.

Written by

Olivia

Eneboparatide (AZP-3601)

Clinical Burden of Patients with Hypoparathyroidism in the United States: A Claims Data Analysis. ASMBR 2021.

Written by

walid

Eneboparatide (AZP-3601)

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics following Single and Multiple Administration of AZP-3601, a Novel Long-Acting PTH Analog, to Healthy Adults. ASMBR 2021.

Written by

walid

Eneboparatide (AZP-3601)

Safety, Tolerability and Pharmacodynamics of AZP-3601, a Novel Long-Acting PTH Analog, in Healthy Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study. e-ECE 2021.

Written by

jpoly4

Eneboparatide (AZP-3601)

cHP Natural History Study: ISPOR Poster

Written by

jpoly4

Upcoming events

39th Congress of the French Society of Endocrinology

Date: October 4-7, 2023 (Marseilles, France)

BIO Japan 2023

Date: October 11-13, 2023 (Yokohama, Japan)

American Society for Bone and Mineral Research 2023 Annual Meeting (ASBMR)

Date: October 13-16, 2023 (Vancouver, Canada)

Acromegaly Awareness Day

Date: November 1, 2023

2023 International HypoPARAthyroidism Conference

Date: November 3-4, 2023 (Sterling, VA)

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
elementor	never	This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_devsite	2 years	This cookie is installed by Google Analytics.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.

News & Media

Press Releases

Presentations

Upcoming events

Social Updates

TWITTER